David Kelleher is CEO and co-founder of 4G Clinical, a venture-backed Randomization and Trial Supply Management (RTSM) company serving the global pharmaceutical market. Kelleher co-founded 4G to accelerate the commercialization of vital medications. 4G Clinical has been named one of Fast Company’s Best Workplaces for Innovators as well as one of the Best Small & Medium Workplaces and Best Workplaces in Healthcare by Great Place to Work® and FORTUNE. Kelleher was also recognized along with his co-founder, 4G Clinical’s CTO Ed Tourtellotte, as EY’s Entrepreneur of the Year® Award finalist in New England.
Previously, David was principal and co-founder of ACME Business Consulting, a management, operations, project and strategy consulting firm headquartered in Portland, Oregon with offices in Seattle and San Diego. Prior to ACME being acquired by North Highland in 2015, the firm was named to the Portland Business Journal’s list of “Fastest-Growing Private 100 Companies” for 8 of the previous 9 years.
Kelleher earned his Bachelor of Science degree in Biology from Duke University and is a former US Army Ranger. Diagnosed with multiple sclerosis in 1996 while serving in the 82nd Airborne Division in Vicenza, Italy, Kelleher is active in finding a cure for the disease. He served on the board of the Oregon Chapter of the National MS Society from 2005–2013 including a two-year stint as the board chair as well as multiple national roles. David currently serves on the Advisory Board of the Duke University Innovation & Entrepreneurship Initiative.